akaritx.com (AKTX) - Bozor qiymatining balans qiymatiga nisbati
Akari Therapeutics daromadlari ilg'or terapiyalarni bozorga olib chiqishga asoslangan bo'lib, bu yerda asosiy katalizator noyob ko'z va immunitet patologiyalarini davolash uchun nomacopanni tijoratlashtirish bo'ladi. 0.75 ga yetgan narx harakati kompaniyaning ikki tomonlama oqsil blokirovka mexanizmiga ega dori vositasini ishlab chiqish tufayli innovator sifatidagi maqomini ta'kidlaydi. Biologik mahsulotlarni ommaviy ishlab chiqarishga tayyorlik ishlab chiqarish liniyalarining hozirgi modernizatsiyasi va shartnoma asosida ishlab chiqarish maydonlarining tasdiqlanishi bilan qo'llab-quvvatlanadi.
Akari Therapeutics PLC (AKTX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Akari Therapeutics|AKTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics plc|AKTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Akari Therapeutics plc|AKTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Akari Therapeutics|Tezkor likvidlik koeffitsiyenti akaritx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Akari Therapeutics - AKTX
Akari Therapeutics (AKTX) kompaniyasining autoimmun patologiyalar terapiyasidagi istiqbolli holati bozor kutganlarini real aktivlar bilan solishtirishni talab qiladi. Ushbu metrika joriy bozor qiymatining kompaniyaning sof kapitaliga nisbatini hisoblaydi. Bozor kapitalizatsiyasi kitob qiymatidan qanchalik yuqori ekanligini tahlil qilish orqali investor kelajakdagi o'sish uchun premiumni aniqlaydi. Yuqori qiymatlar aktivning haddan tashqari sotib olinganligidan dalolat beradi, ko'rsatkichning pasayishi esa biznes baholashining ob'ektivligini tasdiqlaydi.
Raqobatchilar tahlili
ARGX (argenx SE) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati BNTX|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|Astria Therapeutics (ATXS) - Bozor qiymatining balans qiymatiga nisbati|engene.com (ENGN) - Bozor kapitallashuvining balans qiymatiga nisbati|RAPT (RAPT Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Aerovate|Bozor qiymatining balans qiymatiga nisbati Aclaris (ACRS)|KYTX (Kyverna Therapeutics, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TLSA (Tiziana Life Sciences)|Balans qiymatiga nisbatan bozor kapitallashuvi cabalettabio.com (CABA)|VTYX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati THTX (Theratechnologies, Inc.)|AVTX (Avalo Therapeutics Inc.) - Kapitallashuvning sof aktivlarga nisbati|ELDN: Bozor kapitallashuvining balans qiymatiga multiplikatori|AGEN (Agenus) - Bozor kapitallashuvining balans qiymatiga nisbati|CLYM: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ZURA|ATYR - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Adagene Inc. ADAG|Balans qiymatiga nisbatan bozor qiymati IMA|Shattuck Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|EQ - Bozor kapitallashuvining balans qiymatiga nisbati|connectbiopharm.com (CNTB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti InflaRx GmbH IFRX|Kapitallashuvning sof aktivlarga nisbati XFOR (X4 Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati adicetbio.com (ACET)|Celularity - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori INMB (INmune Bio Inc)|Barinthus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Kezar Life Sciences Inc KZR|SABS: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Enlivex Therapeutics Ltd.|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc|GeoVax Labs (GOVX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Bozor kapitallashuvining balans qiymatiga nisbati iBio Corporation (IBIO)|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc. CARM|Bozor kapitallashuvining balans qiymatiga nisbati xtlbio.com XTLB|BOLT: Kapitallashuvning sof aktivlarga nisbati|HCW Biologics Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|APVO (aptevotherapeutics.com) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati AIM|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|gribio.com - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|HIND (Vyome Holdings Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|Bozor kapitallashuvining balans qiymatiga nisbati Indaptus Corp INDP|SCNI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CALI (CalciMedica, Inc.)|affimed.com (AFMD) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Allakos|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGM Bio|Kapitallashuvning sof aktivlarga nisbati ITOS (iTeos Therapeutics)|OCEA (oceanbiomedical.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Balans qiymatiga nisbatan bozor kapitallashuvi Third Harmonic Bio Inc. (THRD)